Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3330

Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Genome to future drug discovery and design in cancer and infectious disease

6th World Congress on Biotechnology

B K Malik

Sharda University, India

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.043

Abstract
Pharmacogenomic databases add to the knowledge of diseases and can be used in different ways, example; to analyze mechanisms to retrieve retrospective and prospective information on clinical presentations, SNP�s based clinical trials, diseases phenotypes, long-term prognosis and efficacy of therapeutic options. These tools are now being applied to pharmaceutical research and development with the view to increase the efficiency of the process and the quality of the product. In silico modeling of proteins for cervical cancer, breast cancer, neurological disorders, cancer and infectious diseases were done employing biological databases. Docking studies were done using synthetic and natural ligands. Pharmacogenomics databases were used for modeling of proteins. It may be concluded that the studies shall help in understanding disease process and drug designing with a view to develop low cost drugs for cancer and infectious diseases.
Biography

B K Malik is the distinguished Professor of Biotechnology, Sharda University, India. His expertise and experience are in the area of Genomics, Bioinformatics and Nanobiotechnology. He has retired in 2006 as Deputy Director in CSIR Institute of Genomics and Integrated Biology (IGIB), Delhi University Campus, Delhi. He was a Consultant at IGIB from 2007-2008. He has teaching and research experience of over 45 years. He has published more than 90 papers in international and national journals.

Email: bk.malik@sharda.ac.in

Top